Breast Cancer Prognosis Assessment
This test can aid in the development of breast cancer treatment plans and avoid conditions such as undertreatment or overtreatment.
Individualized Medication Guidance for Prostate Cancer
This test detects 346 genes, and involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for prostate cancer patients.
The Disease Susceptibility Genetic Test-Anti-Cancer Package A
The test is based on biochip technology. By detecting susceptibility loci in the TP53 gene that are closely related to tumorigenesis, it evaluates its influence on the risk of male tumors and female tumors.
Genetic Testing for Blood Cancer
This test can detect 232 genes associated with blood cancers, and covers all types of leukemia: AML/ALL/CML/CLL/MDS/MPN and various lymphomas.
Karyotype Analysis
Karyotyping can be used to investigate cytogenetic classification, interspecies relationships, chromosome number and structural variation.
CMA Detection
CMA (Chromosomal Microarray Analysis) is a high-resolution, high-throughput molecular karyotyping technique for detecting copy number variation in human genomic DNA.